New research suggests that while on-demand injectable treatments effectively manage Hereditary Angioedema (HAE) attacks, they can also contribute to a significant burden on patients’ quality of life. The study, presented at the recent European Academy of Allergy and Clinical Immunology (EAACI) Congress 2023, investigated the physical, emotional, and social impacts of frequently needing to self-administer these medications.
HAE is a rare genetic disorder characterized by unpredictable, often painful, swelling attacks that can affect various body parts, including the limbs, face, abdomen, and airway. On-demand treatments, which patients carry with them and use at the first sign of an attack, have become a mainstay of HAE management. These treatments work quickly to resolve swelling but require patients to anticipate attacks and be prepared to inject themselves, potentially in public or inconvenient locations.
Researchers conducted a survey of over 300 individuals diagnosed with HAE, all of whom utilized on-demand injectable therapies. The survey focused on assessing the impact of these injections on various aspects of daily living. Results revealed that a substantial proportion of patients experience anxiety and fear related to potential attacks and the necessity of self-treatment. This anticipatory anxiety frequently led to restrictions in social activities, travel, and even professional pursuits.
Furthermore, the research highlighted practical difficulties associated with injections, such as finding appropriate injection sites, dealing with injection site reactions, and the physical discomfort of self-administration. Many patients reported feeling self-conscious about injecting in public, leading to delays in treatment and potentially more severe attacks. The constant preparedness required for on-demand treatment was also linked to a feeling of diminished spontaneity and freedom.
The Need for Prophylactic Options
The findings underscore the need for broader access to and utilization of prophylactic (preventative) treatments for HAE. While on-demand therapies are life-saving during acute episodes, preventing attacks altogether can significantly improve a patient’s overall wellbeing and reduce the burden associated with frequent injections. Preventative treatments, typically administered via regular injection or infusion, aim to keep the levels of a specific protein, C1-inhibitor, within a normal range, thereby minimizing the likelihood of attacks.
“Although on-demand injections are effective at resolving acute HAE symptoms, our study demonstrates that they can come at a substantial cost to patients’ quality of life,” explains Dr. [Name Not Found in Source], a lead researcher on the project. “The constant need for vigilance and the logistics of self-administration contribute to both physical and psychological strain.”
The study advocates for a more personalized approach to HAE management, considering the individual patient’s needs and lifestyle. For those whose lives are significantly impacted by the unpredictability of attacks and the discomfort of frequent injections, prophylactic treatment may be a more suitable long-term solution. Development of more convenient and accessible preventative therapies remains a priority for the HAE research community.
Researchers emphasized the importance of open communication between patients and their healthcare providers to determine the most appropriate treatment plan. This includes a comprehensive assessment of the frequency and severity of attacks, as well as the patient’s individual preferences and concerns. Ultimately, the goal is to empower patients to live full and active lives, minimizing the disruption caused by this challenging condition.
Image Source: Google | Image Credit: Respective Owner
